EVP R&D, Chief Medical Officer
Mon, Nov 3, 2025
Nov 3
5,000 shares @ $19.34
Increased holdings by +6.80%
56th largest trade (out of 152)
Trade made by an officer
10b5-1 scheduled trade
40% win rate · -4.7% median edge vs SPY (15 trades, 90-day · small sample)
Insider trade was 36% below market price